Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Taiyo Corporation Introducing OPELAIII "Subscription Style" Rental Purchase Plan
2022-04-27 06:00
Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-400945 for the Treatment of Acute Myeloid Leukemia
2022-04-27 04:30
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
2022-04-27 00:09
Seegene unveils world's first commercialized '3 Ct' PCR assay
2022-04-26 20:32
PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study
2022-04-26 20:30
PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
2022-04-26 20:00
NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
2022-04-26 20:00
SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform
2022-04-26 19:57
Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu
2022-04-26 19:30
Two Outstanding Hong Kong Startups Named Top Winners of Alibaba Entrepreneurs Fund/HSBC JUMPSTARTER 2022
2022-04-26 17:12
SonoScape S-Fetus 4.0 Release to Simplify Sonography Process
2022-04-26 17:06
Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress
2022-04-26 16:00
Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.
2022-04-26 14:00
The First International COVID-19 Testing Standard Released
2022-04-26 13:02
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Tracking hormonal pathways linking stress with reproductive dysfunction and failure
2022-04-26 12:20
Adge Pharmaceuticals partners with Cyan Bio of Korea to advance treatments for rare pediatric diseases in Asian countries
2022-04-26 07:00
SOFWAVE™ Is This Year's NewBeauty Award Winner!
2022-04-25 20:00
DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions
2022-04-25 20:00
ITRI Named a Double Winner at Edison Awards 2022
2022-04-25 18:15
WuXi AppTec Reports Record First-Quarter In 2022
2022-04-25 17:52
1
256
257
258
259
260
893